Adam Binks is a global technology leader and CEO of Syrenis. With a track record that includes becoming the youngest CEO on the London Stock Exchange’s AIM market, Adam has a deep understanding of how to scale businesses in a data-driven world. At Syrenis, he’s focused on transforming how organizations manage customer data, helping companies navigate the intricate landscape of data privacy while respecting customers’ consent and preferences.
Leaders in pharma’s AI age won’t be remembered for moving the fastest, but for earning and keeping trust along the way. Privacy will determine which companies pull ahead and which fall behind, making it one of the industry’s biggest tests.